Adaptive Biotechnologies CCO Sells $31,176 in Shares

Susan Bobulsky, Chief Commercial Officer of Adaptive Biotechnologies, sold 31,176 shares of the company. The transaction signifies a total value of approximately $31,176. This stock sale may draw attention as investors often analyze insider trading activities for potential market implications. Monitoring such sales can provide insight into the confidence levels of company executives, which may influence investor sentiment towards Adaptive Biotechnologies (ADPT).